Executive Function clinical trials

Explore recruiting executive function clinical trials.

Recruiting executive function studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Executive Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neurodevelopmental outcome after standard dose sevoflurane versus low-dose sevoflurane/dexmedetomidine/remifentanil anaesthesia in young children

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

B7981028 - A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031

Italy, France, Czechia, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

B7981027 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RITLECITINIB IN PEDIATRIC PARTICIPANTS 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA

Spain, France, Czechia, Italy, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase 2 double blind placebo controlled study on the efficacy of Bumetanide for cognitive improvement in children and adolescents with Down syndrome

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of methylphenidate on cancer-related fatigue in patients treated for a brain tumor during childhood or adolescence: Protocol for a randomized, double-blind, placebo-controlled crossover trial - the EMBRAIN trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction.

Hungary, Spain, Italy, Germany, Greece

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Executive Function trials by city

Executive Function in Toronto Executive Function in Vancouver Executive Function in Montreal Executive Function in Calgary Executive Function in Edmonton Executive Function in Ottawa Executive Function in Winnipeg Executive Function in Quebec City Executive Function in Hamilton Executive Function in Kitchener Executive Function in London Executive Function in Halifax Executive Function in New York Executive Function in Los Angeles Executive Function in Chicago Executive Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease